CURE Childhood Cancer is dedicated to discovering a cure for childhood cancer through cutting edge research and providing support to patients and their families through our innovative programming.
Since its inception in 1975, CURE has focused on improving the care, quality of life, and survival rate of children with cancer. The founders – parents and a dedicated pediatric oncologist – joined forces to support laboratory research that would translate into immediate care for children with cancer.
Research is at the core of CURE’s drive to cure childhood cancer. The accomplishments of childhood cancer research teams across the U.S. and the world have made excellent inroads into understanding how to fight this devastating disease. Since the mid-1950s, survival rates have risen from less than 10 percent to almost 80% overall for children with cancer.
The objective of this White Paper is to help you understand the basics of childhood cancer – where we have come from and the challenges ahead in curing this horrible disease. The content of this document has been sourced from the primary children’s cancer research centers including CureSearch (uniting the Children’s Oncology Group and the National Childhood Cancer Foundation), the National Cancer Institute and the National Institute of Health. While this white paper provides a good starting point in helping you understand the challenges ahead, we encourage you to visit the websites of these organizations and institutions for more details.
You will see that while we have made excellent progress, we have a lot more to do in letting children live cancer free.
Click here to view the full White Paper. A very special thank you to Board of Director Vice President, Don Campbell for writing the white paper and Board of Director member Kevin Karem and Advisory Board member, Dr. Harry Findley for their contributions as well.
Founded in 1975, Atlanta, GA-based CURE Childhood Cancer has raised millions of dollars for research and ongoing education of pediatric cancer. CURE currently funds two pediatric oncology Fellows at the Emory University School of Medicine.
”We are so grateful to have Jeff Foxworthy involved with CURE. Jeff is a name and a voice recognized across the nation, and the fact that he is willing to use his notoriety to spread the word about the need for funding for childhood cancer research is extraordinary. He is a generous person and heartfelt in his support of our beloved cause. We are very grateful to him”, says Kristin Connor, CURE Childhood Cancer Executive Director.
Press On provides funding for basic and clinical research relating to neuroblastoma, a pediatric cancer of the sympathetic nervous system. Press On was established in June of 2007 through
In March, kindergartners at The Children’s School in Midtown performed extra chores for parents and friends to raise money for their class community service project. The children donated the money, a total of $587.51, to a special cause, 
“Childhood cancer is the second leading cause of death of children under the age of 18; and yet, research for the disease is shamefully under funded. By focusing on research and education, CURE addresses the words parents desperately want to hear the most – that their child is going to be OK and can live a full and productive life. Atlanta needs and deserves a top notch cancer research and treatment center, and we have that that with the Aflac Cancer Center and Blood Disorders Services at CHOA.”
Each year for the past 34 years, NBC 
